ClinicalTrials.Veeva

Menu

Pulmonary Rehabilitation After Minimal Invasive Surgery in Lung Cancer (PROMISE)

I

Isala

Status

Enrolling

Conditions

Surgery
Lung Cancer

Treatments

Behavioral: Pulmonary rehabilitation

Study type

Interventional

Funder types

Other

Identifiers

NCT05136300
ABR 63724

Details and patient eligibility

About

Morbidity in the post-operative phase of pulmonary surgery is characterised by impairment due to pain, dyspnoea and loss of exercise tolerance. We demonstrated previously that rehabilitation after thoracotomy is limited due to pain. Since minimal invasive surgery is the new standard in lung cancer, resulting in a reduction of postoperative pain, we believe there are new possibilities for post-operative integrated multidisciplinary rehabilitation in lung cancer.

Enrollment

100 estimated patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Patients undergoing elective, minimal invasive surgery with intention to cure.
  2. Age between 18 and 80 years.
  3. ECOG 0 - 2 post-surgery.

Exclusion criteria

  1. Patients with chronic pain

  2. Previous pulmonary surgery

  3. Comorbidity limiting rehabilitation

    1. Rheumatoid arthritis
    2. Severe ischaemic heart disease or myocardial failure; EF ≤ 35 %.
    3. Muscle disease
    4. Fibromyalgia
    5. Neurologic disorders (Parkinson disease, CVA and lesions of the spinal cord)
    6. Psychiatric disorders

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

100 participants in 2 patient groups

Intervention
Experimental group
Description:
An integrated multidisciplinary rehabilitation program on general quality of life (short form 36, SF-36, subdomain general health) in the 12 months postoperative period in patients undergoing elective minimal invasive surgery in lung cancer
Treatment:
Behavioral: Pulmonary rehabilitation
Control
No Intervention group
Description:
Standard of care

Trial contacts and locations

1

Loading...

Central trial contact

Lars Dinjens

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems